Xeomin® is an FDA-approved injectable treatment designed to temporarily improve the appearance of moderate to severe frown lines (glabellar lines) between the eyebrows in adults. Xeomin belongs to the same family as Botox® and Dysport® (botulinum toxin type A), but it does not contain accessory proteins, making it effective for patients who have developed resistance to other botulinum toxin treatments.
Mechanism of Action:
Xeomin® works by blocking acetylcholine, a neurotransmitter that stimulates muscle contraction.
By preventing excessive muscle contractions, Xeomin reduces dynamic wrinkles formed by facial expressions.
This mechanism also allows the skin to relax and repair, improving the appearance of existing wrinkles over time.
Treatment is delivered via a series of very small, precise injections directly into the muscles responsible for frown lines.
Treatment Process:
The procedure is minimally invasive and relatively painless, taking only a few minutes.
Results typically become visible within one week after treatment.
Effects last approximately three to four months, after which repeat treatments may be needed for maintenance.
Advantages of Xeomin®:
Pure botulinum toxin type A without accessory proteins, reducing risk of antibody formation that may limit effectiveness in patients previously treated with Botox® or Dysport®.
Does not require refrigeration before use, making it convenient for clinical practice.
Suitable for patients with resistance to other botulinum toxin products.
FDA-approved and clinically tested for safety and efficacy.
Safety & Side Effects:
Common side effects include injection site pain, swelling, bruising, and temporary eyelid drooping.
Rare but serious symptoms may include difficulty swallowing, speaking, breathing, eye problems, or generalized muscle weakness, which require immediate medical attention.
Always performed by a certified doctor to minimize risks.
Diseases and Conditions:
Moderate to severe glabellar lines
Dynamic facial wrinkles
Muscle contraction-related facial lines
Technologies / Features:
Pure botulinum toxin type A
Targeted neurotransmitter inhibition
Precision injection technology for optimal wrinkle reduction
Suitable for patients resistant to other botulinum toxins
Malaysia
